Side-by-side comparison

LLY vs PFE — Side-by-side comparison

PFE screens cheaper on EV/FCF, LLY has the higher ROIC, LLY has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.

LLY

Eli Lilly & Co.

Price

$1065.00

Market cap

$737.7B

Day %

N/A

PFE

Pfizer Inc.

Price

$25.90

Market cap

$135.4B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best


LLY Target	Eli Lilly & Co.	$737.7B	46.4x	43.4x	77.8%	21.6%	25.8%	N/A	N/A	N/A
PFE	Pfizer Inc.	$135.4B	19.0x	14.8x	9.0%	8.5%	14.5%	N/A	N/A	N/A

LLY implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

43.4x

FCF yield

2.3%

5Y rev CAGR

21.6%

PFE implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

14.8x

FCF yield

6.7%

5Y rev CAGR

8.5%

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for LLY.

Grade C

/ 100

Quality Scorecard

Build-time composite score for PFE.

Grade D

/ 100